Strathmore Capital Advisors, Inc. Abb Vie Inc. Transaction History
Strathmore Capital Advisors, Inc.
- $244 Billion
- Q3 2025
A detailed history of Strathmore Capital Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Strathmore Capital Advisors, Inc. holds 3,918 shares of ABBV stock, worth $903,099. This represents 0.37% of its overall portfolio holdings.
Number of Shares
3,918
Previous 4,050
3.26%
Holding current value
$903,099
Previous $772 Million
17.48%
% of portfolio
0.37%
Previous 0.34%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,307Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$40.9 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.6 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.61 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $408B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...